Mostrando 2 resultados de: 2
Filtros aplicados
Origen
scopus(2)
Metformin a potential pharmacological strategy in late onset Alzheimer’s disease treatment
ReviewAbstract: Alzheimer’s disease (AD) is one of the most devastating brain disorders. Currently, there are no effPalabras claves:Alzheimer’s disease, AMP activated protein kinase AMPK, Beta amyloid, diabetes mellitus, Insulin Resistance, Metformin, Tau protein hyperphosphorylationAutores:Antoni Camins, Cano A., Ettcheto M., Javan M., Manzine P.R., Olloquequi J., Poor S.R., Sanchez-Lopez E.Fuentes:scopusThe implication of the brain insulin receptor in late onset Alzheimer’s disease dementia
ArticleAbstract: Alzheimer’s disease (AD) is progressive neurodegenerative disorder characterized by brain accumulatiPalabras claves:Alzheimer’s, amyloid, COGNITION, insulin receptor, Insulin Resistance, Tau, Type 2 DiabetesAutores:Antoni Camins, Auladell C., Busquets O., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Manzine P.R., Olloquequi J., Poor S.R., Sanchez-Lopez E., Verdaguer E., Zárate C.B.Fuentes:scopus